Literature DB >> 27047551

Update on the Use of SSRIs and SNRIs with Children and Adolescents in Clinical Practice.

E Jane Garland1, Stan Kutcher2, Adil Virani3, Dean Elbe4.   

Abstract

Entities:  

Year:  2016        PMID： 27047551      PMCID： PMC4791100     

Source DB:  PubMed          Journal:  J Can Acad Child Adolesc Psychiatry        ISSN： 1719-8429


× No keyword cloud information.
  43 in total

1.  Child/Adolescent anxiety multimodal study: evaluating safety.

Authors:  Moira A Rynn; John T Walkup; Scott N Compton; Dara J Sakolsky; Joel T Sherrill; Sa Shen; Philip C Kendall; James McCracken; Anne Marie Albano; John Piacentini; Mark A Riddle; Courtney Keeton; Bruce Waslick; Allan Chrisman; Satish Iyengar; John S March; Boris Birmaher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-12-31       Impact factor: 8.829

2.  Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides.

Authors:  G Isacsson; P Holmgren; J Ahlner
Journal:  Acta Psychiatr Scand       Date:  2005-04       Impact factor: 6.392

3.  24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).

Authors:  John Piacentini; Shannon Bennett; Scott N Compton; Phillip C Kendall; Boris Birmaher; Anne Marie Albano; John March; Joel Sherrill; Dara Sakolsky; Golda Ginsburg; Moira Rynn; R Lindsey Bergman; Elizabeth Gosch; Bruce Waslick; Satish Iyengar; James McCracken; John Walkup
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-11-28       Impact factor: 8.829

4.  Comparison among clomipramine, fluoxetine, and placebo for the treatment of anxiety disorders in children and adolescents.

Authors:  Carolina Zadrozny Gouvêa da Costa; Rosa Magaly Campelo Borba de Morais; Dirce Maria Trevisan Zanetta; Gizela Turkiewicz; Francisco Lotufo Neto; Márcia Morikawa; Camila Luisi Rodrigues; Eunice Monteiro Labbadia; Fernando Ramos Asbahr
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-12       Impact factor: 2.576

5.  Safety and tolerability of desvenlafaxine in children and adolescents with major depressive disorder.

Authors:  Robert L Findling; James Groark; Deborah Chiles; Sara Ramaker; Lingfeng Yang; Karen A Tourian
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-03-10       Impact factor: 2.576

6.  A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.

Authors:  Jeffrey R Strawn; Apurva Prakash; Qi Zhang; Beth A Pangallo; Chad E Stroud; Na Cai; Robert L Findling
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2015-01-29       Impact factor: 8.829

7.  The relationship between antidepressant prescription rates and rate of early adolescent suicide.

Authors:  Robert D Gibbons; Kwan Hur; Dulal K Bhaumik; J John Mann
Journal:  Am J Psychiatry       Date:  2006-11       Impact factor: 18.112

8.  Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.

Authors:  John March; Susan Silva; Stephen Petrycki; John Curry; Karen Wells; John Fairbank; Barbara Burns; Marisa Domino; Steven McNulty; Benedetto Vitiello; Joanne Severe
Journal:  JAMA       Date:  2004-08-18       Impact factor: 56.272

Review 9.  Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder.

Authors:  Jeffrey A Bridge; Boris Birmaher; Satish Iyengar; Rémy P Barbe; David A Brent
Journal:  Am J Psychiatry       Date:  2008-12-01       Impact factor: 18.112

10.  Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial.

Authors:  David Brent; Graham Emslie; Greg Clarke; Karen Dineen Wagner; Joan Rosenbaum Asarnow; Marty Keller; Benedetto Vitiello; Louise Ritz; Satish Iyengar; Kaleab Abebe; Boris Birmaher; Neal Ryan; Betsy Kennard; Carroll Hughes; Lynn DeBar; James McCracken; Michael Strober; Robert Suddath; Anthony Spirito; Henrietta Leonard; Nadine Melhem; Giovanna Porta; Matthew Onorato; Jamie Zelazny
Journal:  JAMA       Date:  2008-02-27       Impact factor: 56.272
View more
  16 in total

1. 

Authors:  Tyler Yan; Ran D Goldman
Journal:  Can Fam Physician       Date:  2019-08-14       Impact factor: 3.275

2.  Interprovincial Variation in Antipsychotic and Antidepressant Prescriptions Dispensed in the Canadian Pediatric Population.

Authors:  Nikita Arora; Sandra Knowles; Tara Gomes; Muhammad M Mamdani; David N Juurlink; Corine Carlisle; Mina Tadrous
Journal:  Can J Psychiatry       Date:  2016-07-10       Impact factor: 4.356

3.  Time-to-effect of fluoxetine in children with depression.

Authors:  Tyler Yan; Ran D Goldman
Journal:  Can Fam Physician       Date:  2019-08       Impact factor: 3.275

4.  Antidepressants for Pediatric Patients.

Authors:  Jennifer B Dwyer; Michael H Bloch
Journal:  Curr Psychiatr       Date:  2019-09

5.  Bupropion for smoking cessation in adolescents.

Authors:  Tyler Yan; Ran D Goldman
Journal:  Can Fam Physician       Date:  2021-10       Impact factor: 3.275

Review 6.  Current and Possible Future Therapeutic Options for Huntington's Disease.

Authors:  Mackenzie W Ferguson; Connor J Kennedy; Thulani H Palpagama; Henry J Waldvogel; Richard L M Faull; Andrea Kwakowsky
Journal:  J Cent Nerv Syst Dis       Date:  2022-05-21

7.  What's in a Name? Moving to Neuroscience-Based Nomenclature in Pediatric Psychopharmacology.

Authors:  Ryan S Sultan; Christoph U Correll; Joseph Zohar; Gil Zalsman; Jeremy Veenstra-VanderWeele
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2018-10       Impact factor: 8.829

8.  Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents: A Systematic Review and Meta-analysis.

Authors:  Cosima Locher; Helen Koechlin; Sean R Zion; Christoph Werner; Daniel S Pine; Irving Kirsch; Ronald C Kessler; Joe Kossowsky
Journal:  JAMA Psychiatry       Date:  2017-10-01       Impact factor: 21.596

9.  Autophagy Induction and Accumulation of Phosphorylated Tau in the Hippocampus and Prefrontal Cortex of Adult C57BL/6 Mice Subjected to Adolescent Fluoxetine Treatment.

Authors:  Jorge A Sierra-Fonseca; Minerva Rodriguez; Anapaula Themann; Omar Lira; Francisco J Flores-Ramirez; Javier Vargas-Medrano; Bharathi S Gadad; Sergio D Iñiguez
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

10.  Adolescent Fluoxetine Exposure Induces Persistent Gene Expression Changes in the Hippocampus of Adult Male C57BL/6 Mice.

Authors:  Sergio D Iñiguez; Francisco J Flores-Ramirez; Anapaula Themann; Omar Lira
Journal:  Mol Neurobiol       Date:  2020-11-25       Impact factor: 5.590
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.